Home/Filings/4/0000927066-24-000026
4//SEC Filing

STAFFIERI MICHAEL DAVID 4

Accession 0000927066-24-000026

CIK 0000927066other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:44 PM ET

Size

13.2 KB

Accession

0000927066-24-000026

Insider Transaction Report

Form 4
Period: 2024-02-21
STAFFIERI MICHAEL DAVID
COO, Kidney Care
Transactions
  • Disposition to Issuer

    Common Stock

    2024-02-21$123.00/sh42,610$5,241,03095,077 total
  • Tax Payment

    Common Stock

    2024-02-21$123.00/sh27,902$3,431,94667,175 total
  • Sale

    Common Stock

    2024-02-21$119.81/sh29,488$3,533,02537,687 total
  • Exercise/Conversion

    Common Stock

    2024-02-21100,000100,000 total
    Exercise: $52.41From: 2022-06-20Exp: 2024-06-20Stock Appreciation Rights (100,000 underlying)
  • Exercise/Conversion

    Common Stock

    2024-02-21$52.41/sh+100,000$5,241,000137,687 total
Holdings
  • Common Stock

    (indirect: By Trust)
    158,506
Footnotes (6)
  • [F1]Represents the shares withheld in payment of the base price in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
  • [F2]Represents the shares withheld to satisfy the tax withholding obligation in connection with the exercise of Stock Appreciation Rights reported on this Form 4.
  • [F3]Represents the weighted average sale price of $119.8123. The range of prices for the sale of these shares was $119.43 - $120.49 rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F4]The number of shares reported include shares acquired under DaVita Employee Stock Purchase Plan, an exempt transaction pursuant to Rule 16b-3.
  • [F5]Excludes 89,015 shares previously held by the reporting person directly which were transferred into the 2012 Staffieri Family Trust in transactions exempt from Section 16 reporting pursuant to Rule 16a-13.
  • [F6]The Stock Appreciation Rights were granted on June 20, 2019, which vested 50% each on June 20, 2022 and June 20, 2023.

Issuer

DAVITA INC.

CIK 0000927066

Entity typeother

Related Parties

1
  • filerCIK 0001604063

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:44 PM ET
Size
13.2 KB